Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration

被引:11
|
作者
Palis, Heather [1 ,2 ]
Gan, Wenqi [1 ,3 ]
Xavier, Chloe [1 ]
Desai, Roshni [1 ]
Scow, Marnie [1 ,4 ]
Sedgemore, Kali-Olt [1 ,5 ]
Greiner, Leigh [6 ]
Nicholls, Tonia [2 ,7 ]
Slaunwhite, Amanda [1 ,4 ]
机构
[1] BC Ctr Dis Control, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[3] Univ Connecticut, Dept Publ Hlth Sci, Sch Med, Farmington, CT USA
[4] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[5] Coalit Peers Dismantling Drug War, Vancouver, BC, Canada
[6] BC Correct, Victoria, BC, Canada
[7] BC Mental Hlth & Subst Use Serv, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
DEFICIT HYPERACTIVITY DISORDER; DRUG OVERDOSE; DOUBLE-BLIND; COCAINE-USE; METHYLPHENIDATE; METAANALYSIS; RELEASE;
D O I
10.1001/jamanetworkopen.2022.43653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Studies have suggested a rise in opioid- and stimulant-involved overdoses in recent years in North America. This risk may be acute for individuals who have had contact with the criminal justice system, who are particularly vulnerable to overdose risk. OBJECTIVE To examine the association of opioid and/or stimulant use disorder diagnoses with overdose (fatal and nonfatal) among people with histories of incarceration. DESIGN, SETTING, AND PARTICIPANTS In this cohort study, population-based health and corrections data were retrieved from the British Columbia Provincial Overdose Cohort, which contains a 20% random sample of residents of British Columbia. The analysis included all people in the 20% random sample who had a history of incarceration between January 1, 2010, and December 31, 2014. Outcomes were derived from 5-years of follow-up data (January 1, 2015, to December 31, 2019). Statistical analysis took place from January 2022 to June 2022. EXPOSURES Substance use disorder diagnosis type (ie, opioid use disorder, stimulant use disorder, both, or neither), sociodemographic, health, and incarceration characteristics. MAIN OUTCOMES AND MEASURES Hazard ratios (HRs) are reported from an Andersen-Gill model for recurrent nonfatal overdose events and from a Fine and Gray competing risk model for fatal overdose events. RESULTS The study identified 6816 people (5980 male [87.7%]; 2820 aged <30 years [41.4%)) with histories of incarceration. Of these, 293 (4.3%) had opioid use disorder only, 395 (6.8%) had stimulant use disorder only, and 281 (4.1%) had both diagnoses. During follow-up, 1655 people experienced 4026 overdoses including 3781(93.9%) nonfatal overdoses, and 245 (6.1%) fatal overdoses. In adjusted analyses, the hazard of both fatal (HR, 2.39; 95% CI, 1.48-3.86) and nonfatal (HR, 2.45; 95% CI, 1.94-3.11) overdose was highest in the group with both opioid and stimulant use disorder diagnoses. CONCLUSIONS AND RELEVANCE This cohort study of people with a history of incarceration found an elevated hazard of fatal and nonfatal overdose among people with both opioid and stimulant use disorder diagnoses. This study suggests an urgent need to address the service needs of individuals who have had contact with the criminal justice system and who co-use opioids and stimulants.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Trends in fatal and nonfatal overdose by race among people who inject drugs in Baltimore, Maryland from 1998 to 2019
    Genberg, Becky L.
    Gicquelais, Rachel E.
    Astemborski, Jacquie
    Knight, Jennifer
    Buresh, Megan
    Sun, Jing
    German, Danielle
    Thomas, David L.
    Kirk, Gregory D.
    Mehta, Shruti H.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 229
  • [42] Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder
    Stein, Michael D.
    Flori, Jessica N.
    Risi, Megan M.
    Conti, Micah T.
    Anderson, Bradley J.
    Bailey, Genie L.
    SUBSTANCE ABUSE, 2017, 38 (04) : 389 - 393
  • [43] Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder
    Jones, Jermaine D.
    Campbell, Aimee N.
    Brandt, Laura
    Castillo, Felipe
    Abbott, Rebecca
    Comer, Sandra D.
    SUBSTANCE ABUSE, 2021, 42 (04) : 407 - 411
  • [44] Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans
    Siglin, Jonathan
    Sorkin, John D.
    Namiranian, Khodadad
    AMERICAN JOURNAL ON ADDICTIONS, 2020, 29 (04): : 295 - 304
  • [45] Prescription opioid use and dose trajectories before diagnosis of opioid use disorder or overdose among US adults
    Wei, Yu-Jung
    Chen, Cheng
    Sarayani, Amir
    Fillingim, Roger
    Schmidt, Siegfried
    Winterstein, Almut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 322 - 322
  • [46] Opioid Overdose Prevention with Intranasal Naloxone among People Who Use Methadone
    Walley, Alexander Y.
    Doe-Simkins, Maya
    Quinn, Emily
    Pierce, Courtney
    Ozonoff, Alexander
    Xuan, Ziming
    SUBSTANCE ABUSE, 2012, 33 (02) : 210 - 211
  • [47] Insomnia symptoms are associated with return to use and non-fatal overdose following opioid use disorder treatment
    Hochheimer, Martin
    Ellis, Jennifer D.
    Strickland, Justin C.
    Rabinowitz, Jill A.
    Hobelmann, J. Gregory
    Huhn, Andrew S.
    SLEEP, 2024,
  • [48] Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder
    Shiner, Brian
    Westgate, Christine Leonard
    Bernardy, Nancy C.
    Schnurr, Paula P.
    Watts, Bradley V.
    JOURNAL OF DUAL DIAGNOSIS, 2017, 13 (03) : 201 - 212
  • [49] Patterns of buprenorphine initiation treatment for opioid use disorder and association with opioid-related overdose deaths
    Slavova, Svetla
    Lei, Feitong
    Moga, Daniela
    Slade, Emily
    Hammerslag, Lindsey
    Dasgupta, Nabarun
    Lofwall, Michelle
    Freeman, Patricia
    DiPrete, Bethany
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 49 - 49
  • [50] Factors associated with nonfatal overdose among young opioid users: Heroin and benzodiazepine use, prescription opioid and heroin injection and HCV status
    Mateu-Gelabert, Pedro
    Guarino, Honoria
    Frank, David
    Ruggles, Kelly
    Syckes, Cassandra
    Goodbody, Elizabeth
    Friedman, Samuel R.
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E131 - E131